| 0.006 |
Cardiovascular Diseases |
NA |
BeFree,GAD |
|
Detail |
| 0.120 |
Catalepsy |
NA |
CTD_human |
|
Detail |
| 0.080 |
brain ischemia |
NA |
RGD |
|
Detail |
| <0.001 |
dental enamel hypoplasia |
NA |
BeFree |
|
Detail |
| 0.081 |
depressive disorder |
NA |
BeFree,RGD |
|
Detail |
| <0.001 |
Diabetes |
NA |
BeFree |
|
Detail |
| <0.001 |
diabetes mellitus |
NA |
BeFree |
|
Detail |
| 0.080 |
Diabetes Mellitus, Experimental |
NA |
RGD |
|
Detail |
| 0.006 |
Diabetes Mellitus, Insulin-Dependent |
NA |
BeFree,GAD |
|
Detail |
| 0.003 |
Diabetes Mellitus, Non-Insulin-Dependent |
NA |
BeFree,GAD |
|
Detail |
| <0.001 |
DiGeorge syndrome |
NA |
BeFree |
|
Detail |
| <0.001 |
Dwarfism |
NA |
BeFree |
|
Detail |
| <0.001 |
Dyskinetic syndrome |
NA |
BeFree |
|
Detail |
| 0.120 |
Dyskinesia, Drug-Induced |
NA |
CTD_human |
|
Detail |
| 0.132 |
dystonia |
NA |
BeFree,CTD_human,LHGDN |
|
Detail |
| 0.080 |
epilepsy |
NA |
RGD |
|
Detail |
| <0.001 |
Fanconi anemia |
NA |
BeFree |
|
Detail |
| 0.002 |
chronic fatigue syndrome |
NA |
GAD |
|
Detail |
| <0.001 |
ganglioneuroma |
NA |
BeFree |
|
Detail |
| 0.120 |
Heart Diseases |
NA |
CTD_human |
|
Detail |
| 0.080 |
Heart failure |
NA |
RGD |
|
Detail |
| 0.001 |
Herpes Simplex Infections |
NA |
BeFree |
|
Detail |
| <0.001 |
Von Hippel-Lindau syndrome |
NA |
BeFree |
|
Detail |
| <0.001 |
HIV Infections |
NA |
BeFree |
|
Detail |
| 0.080 |
hyperprolactinemia |
NA |
RGD |
|
Detail |
| 0.099 |
Hypertensive disease |
NA |
BeFree,GAD,LHGDN,RGD |
|
Detail |
| 0.080 |
Hypertension, Portal |
NA |
RGD |
|
Detail |
| 0.080 |
hypoglycemia |
NA |
RGD |
|
Detail |
| 0.005 |
Insulin resistance |
NA |
GAD |
|
Detail |
| 0.120 |
Learning Disorders |
NA |
CTD_human |
|
Detail |
| <0.001 |
Lesch-Nyhan syndrome |
NA |
BeFree |
|
Detail |
| <0.001 |
acute myelomonocytic leukemia |
NA |
BeFree |
|
Detail |
| 0.080 |
Liver Cirrhosis, Experimental |
NA |
RGD |
|
Detail |
| <0.001 |
lymphoma |
NA |
BeFree |
|
Detail |
| 0.080 |
Machado-Joseph disease |
NA |
RGD |
|
Detail |
| <0.001 |
Malabsorption Syndrome |
NA |
BeFree |
|
Detail |
| <0.001 |
Malignant neoplasm of stomach |
NA |
BeFree |
|
Detail |
| <0.001 |
multiple endocrine neoplasia type 2A |
NA |
BeFree |
|
Detail |
| 0.003 |
multiple sclerosis |
NA |
BeFree,GAD |
|
Detail |
| 0.003 |
myocardial infarction |
NA |
BeFree,GAD |
|
Detail |
| <0.001 |
Neoplasm Metastasis |
NA |
BeFree |
|
Detail |
| 0.120 |
Nerve Degeneration |
NA |
CTD_human |
|
Detail |
| <0.001 |
nervous system disorder |
NA |
BeFree |
|
Detail |
| 0.141 |
neuroblastoma |
NA |
BeFree,CTD_human,LHGDN |
|
Detail |
| <0.001 |
Neuromuscular Diseases |
NA |
BeFree |
|
Detail |
| 0.003 |
nicotine dependence |
NA |
BeFree,GAD |
|
Detail |
| <0.001 |
Nodule |
Both the 9.5-cm cardiac mass and 0.5-cm lung nodule were positive for chromogran... |
BeFree |
24402737 |
Detail |
| 0.002 |
obesity |
NA |
GAD |
|
Detail |
| 0.003 |
Metabolic syndrome X |
We found that genotype Met/Met of the Val66Met polymorphism of the brain-derived... |
BeFree |
20163778 |
Detail |
| 0.081 |
depressive disorder |
We found that genotype Met/Met of the Val66Met polymorphism of the brain-derived... |
BeFree |
20163778 |
Detail |
| 0.097 |
Parkinson disease |
In the present study we compared monolayer-cultured (aMSC) and spheroid (sMSC) M... |
BeFree,GAD,LHGDN,RGD |
25120226 |
Detail |
| 0.097 |
Parkinson disease |
Loss of the Grx1 homolog also exacerbated the neurodegenerative phenotype in oth... |
BeFree,GAD,LHGDN,RGD |
25355420 |
Detail |
| 0.097 |
Parkinson disease |
Thus, the hTH-GFP reporter rat should be a valuable tool for Parkinson's disease... |
BeFree,GAD,LHGDN,RGD |
25462571 |
Detail |
| <0.001 |
Phenylketonurias |
NA |
BeFree |
|
Detail |
| 0.123 |
pheochromocytoma |
NA |
BeFree,CTD_human |
|
Detail |
| 0.001 |
Pituitary Diseases |
NA |
BeFree |
|
Detail |
| 0.080 |
polycystic ovary syndrome |
NA |
RGD |
|
Detail |
| 0.002 |
pre-eclampsia |
NA |
GAD |
|
Detail |
| <0.001 |
prolactinoma |
NA |
BeFree |
|
Detail |
| 0.002 |
Prostatic Neoplasms |
NA |
GAD |
|
Detail |
| <0.001 |
Psychotic Disorders |
We have searched for association between 119 SNPs in genes implicated in monoami... |
BeFree |
25073638 |
Detail |
| <0.001 |
Rett syndrome |
NA |
BeFree |
|
Detail |
| 0.031 |
schizophrenia |
NA |
BeFree,GAD,LHGDN |
|
Detail |
| <0.001 |
paranoid schizophrenia |
NA |
BeFree |
|
Detail |
| <0.001 |
Spastic paraplegia |
NA |
BeFree |
|
Detail |
| 0.005 |
Stomach Neoplasms |
NA |
GAD,LHGDN |
|
Detail |
| <0.001 |
Cerebrovascular accident |
NA |
BeFree |
|
Detail |
| 0.080 |
Substance Withdrawal Syndrome |
NA |
BeFree,RGD |
|
Detail |
| 0.006 |
sudden infant death syndrome |
Tyrosine hydroxylase TH01 9.3 allele in the occurrence of sudden infant death sy... |
BeFree,GAD,LHGDN |
24975687 |
Detail |
| <0.001 |
progressive supranuclear palsy |
NA |
BeFree |
|
Detail |
| <0.001 |
Tobacco Dependence |
NA |
BeFree |
|
Detail |
| 0.005 |
Tobacco use disorder |
NA |
GAD,LHGDN |
|
Detail |
| <0.001 |
Gilles de la Tourette syndrome |
NA |
BeFree |
|
Detail |
| 0.080 |
uremia |
NA |
RGD |
|
Detail |
| <0.001 |
Virus Diseases |
NA |
BeFree |
|
Detail |
| <0.001 |
vitiligo |
NA |
BeFree |
|
Detail |
| 0.002 |
Weight Gain |
NA |
GAD |
|
Detail |
| 0.003 |
Wolfram syndrome |
NA |
LHGDN |
|
Detail |
| <0.001 |
Albinism, Oculocutaneous |
NA |
BeFree |
|
Detail |
| <0.001 |
essential hypertension |
NA |
BeFree |
|
Detail |
| 0.001 |
Encephalopathies |
NA |
BeFree |
|
Detail |
| <0.001 |
Polyglandular Type I Autoimmune Syndrome |
NA |
BeFree |
|
Detail |
| <0.001 |
pancreatic cholera |
NA |
BeFree |
|
Detail |
| 0.002 |
Migraine Disorders |
NA |
GAD |
|
Detail |
| <0.001 |
Malnutrition |
NA |
BeFree |
|
Detail |
| <0.001 |
Rhabdomyosarcoma, Embryonal |
NA |
BeFree |
|
Detail |
| <0.001 |
ganglioneuroblastoma |
NA |
BeFree |
|
Detail |
| <0.001 |
Shprintzen syndrome |
NA |
BeFree |
|
Detail |
| <0.001 |
Chronic schizophrenia |
NA |
BeFree |
|
Detail |
| 0.002 |
Personality Traits |
NA |
GAD |
|
Detail |
| 0.124 |
Parkinsonian Disorders |
NA |
BeFree,CTD_human |
|
Detail |
| 0.007 |
Neoplasm, Residual |
NA |
BeFree,LHGDN |
|
Detail |
| <0.001 |
Hyperphenylalaninemia, BH4-Deficient, B |
NA |
BeFree |
|
Detail |
| <0.001 |
Disseminated neuroblastoma |
NA |
BeFree |
|
Detail |
| <0.001 |
Malignant Childhood Neoplasm |
NA |
BeFree |
|
Detail |
| <0.001 |
stage, neuroblastoma |
NA |
BeFree |
|
Detail |
| <0.001 |
High altitude pulmonary edema |
NA |
BeFree |
|
Detail |
| <0.001 |
optic nerve glioma |
NA |
BeFree |
|
Detail |
| 0.007 |
Malignant neoplasm of prostate |
NA |
BeFree,GAD |
|
Detail |
| 0.006 |
Dystonia Disorders |
NA |
BeFree,GAD |
|
Detail |
| 0.005 |
Dystonia, Diurnal |
NA |
BeFree |
|
Detail |
| <0.001 |
Inattention |
NA |
BeFree |
|
Detail |
| 0.120 |
Hyperactive behavior |
NA |
CTD_human |
|
Detail |
| 0.005 |
body mass |
NA |
GAD |
|
Detail |
| 0.003 |
Metabolic syndrome X |
NA |
BeFree,GAD |
|
Detail |
| 0.008 |
Mood Disorders |
NA |
BeFree,GAD,LHGDN |
|
Detail |
| <0.001 |
prostate carcinoma |
NA |
BeFree |
|
Detail |
| <0.001 |
Ewings sarcoma-primitive neuroectodermal tumor (PNET) |
NA |
BeFree |
|
Detail |
| <0.001 |
stomach carcinoma |
NA |
BeFree |
|
Detail |
| 0.015 |
Central neuroblastoma |
NA |
BeFree |
|
Detail |
| <0.001 |
Dissecting aneurysm of the thoracic aorta |
Specifically, we found a pair of TH-positive cells in the ventral region of the ... |
BeFree |
25217291 |
Detail |
| 0.080 |
Infarction, Middle Cerebral Artery |
NA |
RGD |
|
Detail |
| <0.001 |
Classical phenylketonuria |
NA |
BeFree |
|
Detail |
| <0.001 |
Hyperphenylalaninemia, Non-Phenylketonuric |
NA |
BeFree |
|
Detail |
| <0.001 |
Parkinsonism, Juvenile |
NA |
BeFree |
|
Detail |
| 0.003 |
Lewy Body Disease |
NA |
BeFree,LHGDN |
|
Detail |
| <0.001 |
Stage 4S neuroblastoma |
NA |
BeFree |
|
Detail |
| 0.003 |
attention deficit hyperactivity disorder |
NA |
BeFree,GAD |
|
Detail |
| <0.001 |
Mild cognitive disorder |
NA |
BeFree |
|
Detail |
| 0.002 |
Blood pressure finding |
NA |
GAD |
|
Detail |
| 0.005 |
Systemic arterial pressure |
NA |
GAD |
|
Detail |
| <0.001 |
Segmental vitiligo |
NA |
BeFree |
|
Detail |
| <0.001 |
Generalized vitiligo |
NA |
BeFree |
|
Detail |
| <0.001 |
Tendinosis |
NA |
BeFree |
|
Detail |
| <0.001 |
Dystonia 3, Torsion, X-Linked |
NA |
BeFree |
|
Detail |
| 0.004 |
MAJOR AFFECTIVE DISORDER 2 |
NA |
BeFree |
|
Detail |
| <0.001 |
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding) |
NA |
BeFree |
|
Detail |
| 0.004 |
Dopa-responsive dystonia |
NA |
BeFree |
|
Detail |
| 0.002 |
MAJOR AFFECTIVE DISORDER 1 |
NA |
BeFree |
|
Detail |
| 0.002 |
MAJOR AFFECTIVE DISORDER 4 |
NA |
BeFree |
|
Detail |
| 0.002 |
MAJOR AFFECTIVE DISORDER 5 |
NA |
BeFree |
|
Detail |
| 0.002 |
MAJOR AFFECTIVE DISORDER 6 |
NA |
BeFree |
|
Detail |
| 0.120 |
liver carcinoma |
NA |
BeFree,CTD_human |
|
Detail |
| 0.361 |
DYSTONIA, DOPA-RESPONSIVE, WITH OR WITHOUT HYPERPHENYLALANINEMIA, AUTOSOMAL RECESSIVE (disorder) |
NA |
BeFree,CTD_human,ORPHANET,UNIPROT |
|
Detail |
| 0.002 |
Major affective disorder 7 |
NA |
BeFree |
|
Detail |
| 0.002 |
MAJOR AFFECTIVE DISORDER 8 |
NA |
BeFree |
|
Detail |
| 0.002 |
MAJOR AFFECTIVE DISORDER 9 |
NA |
BeFree |
|
Detail |
| 0.002 |
Weight Gain Adverse Event |
NA |
GAD |
|
Detail |
| <0.001 |
FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) |
NA |
BeFree |
|
Detail |
| <0.001 |
Autoimmune polyendocrinopathy syndrome, type 1 |
NA |
BeFree |
|
Detail |
| 0.120 |
intellectual disability |
NA |
CTD_human |
|
Detail |
| <0.001 |
Adjustment Disorders |
NA |
BeFree |
|
Detail |
| <0.001 |
Albinism |
NA |
BeFree |
|
Detail |
| 0.003 |
Alcohol Withdrawal Delirium |
NA |
BeFree,GAD |
|
Detail |
| 0.004 |
Alcoholic Intoxication, Chronic |
NA |
BeFree,GAD |
|
Detail |
| <0.001 |
Alzheimer's disease |
NA |
BeFree |
|
Detail |
| 0.005 |
As If Personality |
NA |
GAD |
|
Detail |
| <0.001 |
asthma |
NA |
BeFree |
|
Detail |
| 0.005 |
autistic disorder |
NA |
BeFree,GAD |
|
Detail |
| <0.001 |
Autoimmune Diseases |
NA |
BeFree |
|
Detail |
| 0.003 |
Mental disorders |
NA |
BeFree,GAD |
|
Detail |
| 0.013 |
bipolar disorder |
NA |
BeFree,GAD |
|
Detail |
| 0.003 |
borderline personality disorder |
NA |
BeFree,GAD |
|
Detail |
| 0.120 |
Brain Diseases |
NA |
CTD_human |
|
Detail |
